达意隆(002209.SZ)已收到2019年度品牌培育项目的政府补助112万元
格隆汇12月24日丨达意隆(002209.SZ)公布,根据《广东省商务厅关于中央财政2019年度外经贸发展专项资金(开拓重点事项)项目计划的公示》,公司获得2019年度外经贸发展专项资金外贸中小企业开拓市场项目(“开拓市场项目”)的政府补助9.936万元以及2019年度外经贸发展专项资金品牌培育项目(“品牌培育项目”)的政府补助112万元。以上两项政府补助为现金形式,与公司日常经营活动相关,但不具有可持续性。
公司已于2019年12月23日收到2019年度品牌培育项目的政府补助112万元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.